Related Experiment Video

Updated: Jun 8, 2025

Macrophage Differentiation and Polarization into an M2-Like Phenotype using a Human Monocyte-Like THP-1 Leukemia Cell Line
06:38

Macrophage Differentiation and Polarization into an M2-Like Phenotype using a Human Monocyte-Like THP-1 Leukemia Cell Line

Published on: August 2, 2021

27.2K

TYROBP promotes the spread of pancreatic cancer by causing M2 TAM polarization

Dingwen Zhong1,2,3, Yonghui Liao3, Wenhui Chen3

  • 1Department of Hepatobiliary Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.

Journal of Gastroenterology and Hepatology
|November 4, 2024
PubMed
Abstract

Insights

Tyrosine kinase binding protein (TYROBP) from M2 TAMs exosomes promotes pancreatic cancer metastasis by affecting migration and invasion via the CD44/AKT/ERK pathway. TYROBP is a potential therapeutic target for pancreatic cancer.

Area of Science:

  • Oncology
  • Immunology
  • Cell Biology

Background:

  • M2-polarized tumor-associated macrophages (M2 TAMs) and their exosomes are implicated in cancer progression.
  • The role of M2 TAM-derived exosomes in pancreatic cancer (PC) pathogenesis is not well understood.
  • Tyrosine kinase binding protein (TYROBP) is present in M2 TAM exosomes and may transfer to PC cells.

Purpose of the Study:

  • To investigate the role of TYROBP in pancreatic cancer progression.
  • To determine the mechanisms by which TYROBP influences PC cell behavior, particularly metastasis.
  • To explore TYROBP as a potential therapeutic target for pancreatic cancer.

Main Methods:

  • Confirmed TYROBP presence in M2 TAM exosomes and its transfer to PC cells.
  • Assessed TYROBP's impact on PC proliferation, apoptosis, migration, and invasion in vitro and in vivo.
  • Investigated TYROBP's role in PC metastasis, focusing on the CD44/AKT/ERK signaling pathway.

Main Results:

  • TYROBP did not significantly alter PC cell proliferation or apoptosis.
  • TYROBP inhibited PC cell migration and invasion via the CD44/AKT/ERK pathway.
  • Both in vitro and in vivo studies demonstrated that TYROBP enhances PC metastasis.

Conclusions:

  • TYROBP directly promotes pancreatic cancer metastasis through its association with M2 TAM polarization.
  • TYROBP represents a promising novel therapeutic target for pancreatic cancer interventions.
Keywords:
TYROBPexosomespancreatic cancertumor‐associated macrophages

More Related Videos

Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma06:21

Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma

Published on: November 19, 2019

11.0K
Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity06:16

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity

Published on: December 7, 2019

12.6K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.4K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
3.9K